September 24, 2025 a 06:01 pm
SOLV: Fundamental Ratio Analysis - Solventum Corporation
Solventum Corporation is an emerging healthcare company with a versatile portfolio spanning multiple segments. Despite its relatively recent incorporation, it holds a promising position for addressing critical customer and patient needs. Potential investors should consider the diverse range of solutions and technologies offered.
Fundamental Rating (H2)
The company's fundamental strength is rated at a B level, indicating a solid financial foundation despite being newly established. Here are detailed scores in various key financial areas:
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
Historical Rating
Tracking changes in the company's financial indicators provides a comprehensive view of its performance and strategic adjustments over time:
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-24 | 3 | 5 | 4 | 4 | 1 | 1 | 2 |
| Previously | 0 | 5 | 4 | 4 | 1 | 1 | 2 |
Analyst Price Targets
The price target consensus among analysts provides a single vision for the stock's expected market direction, exposing a consistent forecast across all price categories:
| High | Low | Median | Consensus |
|---|---|---|---|
| 103 | 103 | 103 | 103 |
Analyst Sentiment
Analyst recommendations reveal a predominantly positive sentiment with a few reservations:
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 3 | |
| Hold | 3 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Solventum Corporation, as a young healthcare player, demonstrates potential with its broad spectrum of service segments. The company's current fundamental scores showcase robust areas like cash flow and asset management, albeit some debt concerns. Analysts generally lean towards a 'Buy' rating, reflecting the company's potential traction in the market. While promising, investors should remain aware of the inherent risks involved in investing in a recently incorporated entity. Overall, Solventum Corporation stands as a promising proposition for risk-tolerant investors seeking growth in the healthcare sector.